Our proprietary carbon microspheres feature excellent biocompatibility, physical stability and radiation resistance, and enables efficient and stable loading of radioisotopes without relying on the reactor-based irradiation, providing significant advantages in product performance and accessibility. The carbon micrsopheres are currently at different stages of clinical development.

Our company has developed multiple theranostic pairs for radioligand therapy, supporting precision and personalized treatment. These drug candidates are currently at various stages of clinical development or early research.